Literature DB >> 17316722

Expression of cyclooxygenase-2, P-glycoprotein and multi-drug resistance-associated protein in canine transitional cell carcinoma.

J-Y Lee1, S Tanabe, H Shimohira, Y Kobayashi, T Oomachi, S Azuma, K Ogihara, H Inokuma.   

Abstract

Cyclooxygenase-2 (COX-2), P-glycoprotein (P-gp) and multi-drug resistance-associated protein (MRP) are considered important tumor-associated proteins in humans and dogs. In the present study, we immunohistochemically evaluated the expression of these proteins in canine patients with transitional cell carcinoma (TCC). Of 52 cases, 30 (57.7%) were positive for COX-2, 40 (76.9%) for P-gp, and only 10 (19.2%) for MRP. In addition, 27 samples (27/52, 51.9%) were positive for two markers, while 3 (5.7%) and 5 (9.6%) cases were positive and negative, respectively, for all three markers. No significant correlations were seen for COX-2 and P-gp on Fisher's exact test and Mann-Whitney's test, but a significance was seen on Spearman's rank correlation analysis using the IHC scoring system (P=0.043). These results suggest that P-gp expression is induced by overexpression of COX-2 in canine patients with TCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316722     DOI: 10.1016/j.rvsc.2006.12.012

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  8 in total

1.  Transitional cell carcinoma of the urinary bladder in a 14-year-old dog.

Authors:  Melissa Caswell
Journal:  Can Vet J       Date:  2011-06       Impact factor: 1.008

2.  Resveratrol reverses P-glycoprotein-mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF-κB and p38 MAPK signaling pathways.

Authors:  Rui Zhang; Ming Lu; Zhen Zhang; Xiliang Tian; Shouyu Wang; Decheng Lv
Journal:  Oncol Lett       Date:  2016-09-14       Impact factor: 2.967

3.  Molecular imaging of cyclooxygenase-2 in canine transitional cell carcinomas in vitro and in vivo.

Authors:  Maria Cekanova; Md Jashim Uddin; Joseph W Bartges; Amanda Callens; Alfred M Legendre; Kusum Rathore; Laura Wright; Amanda Carter; Lawrence J Marnett
Journal:  Cancer Prev Res (Phila)       Date:  2013-03-26

4.  Single-dose safety and pharmacokinetic evaluation of fluorocoxib A: pilot study of novel cyclooxygenase-2-targeted optical imaging agent in a canine model.

Authors:  Maria Cekanova; Md Jashim Uddin; Alfred M Legendre; Gina Galyon; Joseph W Bartges; Amanda Callens; Tomas Martin-Jimenez; Lawrence J Marnett
Journal:  J Biomed Opt       Date:  2012-11       Impact factor: 3.170

5.  Sinomenine sensitizes multidrug-resistant colon cancer cells (Caco-2) to doxorubicin by downregulation of MDR-1 expression.

Authors:  Zhen Liu; Zhi-Jun Duan; Jiu-Yang Chang; Zhi-Feng Zhang; Rui Chu; Yu-Ling Li; Ke-Hang Dai; Guang-Quan Mo; Qing-Yong Chang
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

Review 6.  Mechanisms of Drug Resistance in Veterinary Oncology- A Review with an Emphasis on Canine Lymphoma.

Authors:  Maurice Zandvliet; Erik Teske
Journal:  Vet Sci       Date:  2015-08-12

Review 7.  Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans.

Authors:  Maria Malvina Tsamouri; Thomas M Steele; Maria Mudryj; Michael S Kent; Paramita M Ghosh
Journal:  Biomedicines       Date:  2021-10-14

8.  Pharmacokinetic characterization of fluorocoxib D, a cyclooxygenase-2-targeted optical imaging agent for detection of cancer.

Authors:  Maria Cekanova; Sony Pandey; Shelly Olin; Phillip Ryan; Jennifer E Stokes; Silke Hecht; Tomas Martin-Jimenez; Md Jashim Uddin; Lawrence J Marnett
Journal:  J Biomed Opt       Date:  2020-08       Impact factor: 3.170

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.